We are live on
!
Find out more
DCP
DSM Capital Partners Portfolio holdings
AUM
$5.66B
1-Year Est. Return
27.45%
This Fund
S&P 500
This Quarter
Est. Return
-3.22%
1 Year Est. Return
+27.45%
3 Year Est. Return
+126.04%
5 Year Est. Return
+156.94%
10 Year Est. Return
+722.36%
AUM
$5.37B
AUM Growth
-$492M
(-8.4%)
Cap. Flow
-$191M
Cap. Flow
% of AUM
-3.56%
Top 10 Holdings %
Top 10 Hldgs %
51.31%
Holding
47
New
6
Increased
18
Reduced
14
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$171M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$108M |
| 3 |
Intuitive Surgical
ISRG
|
+$102M |
| 4 |
SRCL
Stericycle Inc
SRCL
|
+$91.7M |
| 5 |
Visa
V
|
+$79.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$346M |
| 2 |
Apple
AAPL
|
+$143M |
| 3 |
Comcast
CMCSA
|
+$140M |
| 4 |
MON
Monsanto Co
MON
|
+$134M |
| 5 |
Abbott
ABT
|
+$134M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.09% |
| 2 | Consumer Discretionary | 16.52% |
| 3 | Financials | 14.62% |
| 4 | Technology | 13.78% |
| 5 | Communication Services | 10.93% |
Similar funds
F
RMDI
AIM
O
AC
CRC
ACM
PI
DSM Capital Partners's Q3 2015 Portfolio in Review
As of Q3 2015, DSM Capital Partners held 47 positions worth $5.37B, down 8.4% from $5.86B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
DSM Capital Partners withdrew a net $191M in Q3 2015, closing 8 positions and reducing 14 holdings. Its most notable exit was Biogen, an estimated $346M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, DSM Capital Partners opened a new position in Adobe worth $174M.
- DSM Capital Partners's largest Q3 2015 buy was Adobe: 2,110,502 shares worth $174M.
- DSM Capital Partners added most to Visa in Q3 2015, an estimated $79.7M increase.
- DSM Capital Partners's biggest Q3 2015 reduction was Abbott, cutting an estimated $134M.
- DSM Capital Partners fully exited Biogen in Q3 2015, selling an estimated $346M.
- DSM Capital Partners's ten largest holdings make up 51% of its $5.37B portfolio in Q3 2015.
- DSM Capital Partners opened 6 new positions and closed 8 in Q3 2015.
- DSM Capital Partners's portfolio value fell 8.4% quarter-over-quarter to $5.37B.
Based on DSM Capital Partners's 13F filing for Q3 2015, filed 13 Nov 2015.